Schwartz J R, Duesberg S, Duesberg P H
Department of Molecular and Cell Biology, University of California, Berkeley 94720-3206, USA.
Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2460-4. doi: 10.1073/pnas.92.7.2460.
Oncogenic retroviruses carry coding sequences that are transduced from cellular protooncogenes. Natural transduction involves two nonhomologous recombinations and is thus extremely rare. Since transduction has never been reproduced experimentally, its mechanism has been studied in terms of two hypotheses: (i) the DNA model, which postulates two DNA recombinations, and (ii) the RNA model, which postulates a 5' DNA recombination and a 3' RNA recombination occurring during reverse transcription of viral and protooncogene RNA. Here we use two viral DNA constructs to test the prediction of the DNA model that the 3' DNA recombination is achieved by conventional integration of a retroviral DNA 3' of the chromosomal protooncogene coding region. For the DNA model to be viable, such recombinant viruses must be infectious without the purportedly essential polypurine tract (ppt) that precedes the 3' long terminal repeat (LTR) of all retroviruses. Our constructs consist of a ras coding region from Harvey sarcoma virus which is naturally linked at the 5' end to a retroviral LTR and artificially linked at the 3' end either directly (construct NdN) or by a cellular sequence (construct SU) to the 5' LTR of a retrovirus. Both constructs lack the ppt, and the LTR of NdN even lacks 30 nucleotides at the 5' end. Both constructs proved to be infectious, producing viruses at titers of 10(5) focus-forming units per ml. Sequence analysis proved that both viruses were colinear with input DNAs and that NdN virus lacked a ppt and the 5' 30 nucleotides of the LTR. The results indicate that DNA recombination is sufficient for retroviral transduction and that neither the ppt nor the complete LTR is essential for retrovirus replication. DNA recombination explains the following observations by others that cannot be reconciled with the RNA model: (i) experimental transduction is independent of the packaging efficiency of viral RNA, and (ii) experimental transduction may invert sequences with respect to others, as expected for DNA recombination during transfection.
致癌逆转录病毒携带从细胞原癌基因转导而来的编码序列。自然转导涉及两次非同源重组,因此极为罕见。由于转导从未在实验中重现,其机制已根据两种假说来研究:(i)DNA模型,假定有两次DNA重组;(ii)RNA模型,假定在病毒和原癌基因RNA的逆转录过程中发生一次5' DNA重组和一次3' RNA重组。在这里,我们使用两种病毒DNA构建体来检验DNA模型的预测,即3' DNA重组是通过染色体原癌基因编码区3' 端逆转录病毒DNA的常规整合来实现的。要使DNA模型可行,此类重组病毒必须具有传染性,且无需所有逆转录病毒3' 长末端重复序列(LTR)之前所谓必不可少的多聚嘌呤序列(ppt)。我们的构建体由来自哈维肉瘤病毒的ras编码区组成,该编码区在5' 端自然连接到一个逆转录病毒LTR,并在3' 端通过细胞序列(构建体SU)或直接(构建体NdN)连接到另一个逆转录病毒的5' LTR。两种构建体均缺乏ppt,NdN的LTR在5' 端甚至还缺少30个核苷酸。两种构建体均被证明具有传染性,产生的病毒滴度为每毫升10(5) 个灶形成单位。序列分析证明,两种病毒均与输入DNA共线性,且NdN病毒缺乏ppt和LTR的5' 端30个核苷酸。结果表明,DNA重组足以实现逆转录病毒转导,且ppt和完整的LTR对于逆转录病毒复制均非必不可少。DNA重组解释了其他人的以下观察结果,这些结果与RNA模型无法协调一致:(i)实验性转导与病毒RNA的包装效率无关,(ii)实验性转导可能会使序列相对于其他序列发生颠倒,这正如转染过程中DNA重组所预期的那样。